When Illumina (NASDAQ: ILMN) announced it had agreed to acquire Pacific Biosciences (NASDAQ: PACB) in November 2018, the already concentrated world of DNA sequencing was bracing for further consolidation.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,